Sun.Jul 14, 2024

article thumbnail

Where's the Synthetic Blood?

Codon

Dr. Keith Neeves gives a history of blood transfusions and explains why it will be difficult to scale up the creation of synthetic blood for Issue 03 of Asimov Press. We are mostly blood. Of the 36 trillion cells in the human body, 32 trillion are blood cells. These blood cells synchronize the delivery of oxygen to every tissue in your body, fight pathogens, and heal wounds.

article thumbnail

Have Fun in the Sun, But Protect Your Skin, Expert Says

Drugs.com

SUNDAY, July 14, 2024 — Roughly 20% of Americans are diagnosed with skin cancer at some point in their lives, but it's not inevitable.Skin cancer is not only the most common cancer, it's also the most preventable. Most of the time, too much sun e.

103
103
article thumbnail

Which pharmaceutical drugs have the most drug patents in Austria?

Drug Patent Watch

This chart shows the drugs with the most patents in Austria. Patents must be filed in each country (or, in some cases regional patent office) where patent protection is desired.

article thumbnail

LatinX@Broad Presents The René Salazar Speaker Series: Mariana Matus

Broad Institute

LatinX@Broad Presents The René Salazar Speaker Series: Mariana Matus By Rose Circeo July 14, 2024 Breadcrumb Home LatinX@Broad Presents The René Salazar Speaker Series: Mariana Matus Dr. Mariana Matus My Journey of spinning off my PhD research into a startup Learn more about the LatinX@Broad speaker series.

article thumbnail

From Diagnosis to Delivery: How AI is Revolutionizing the Patient Experience

Speaker: Simran Kaur, Founder & CEO at Tattva Health Inc.

The healthcare landscape is being revolutionized by AI and cutting-edge digital technologies, reshaping how patients receive care and interact with providers. In this webinar led by Simran Kaur, we will explore how AI-driven solutions are enhancing patient communication, improving care quality, and empowering preventive and predictive medicine. You'll also learn how AI is streamlining healthcare processes, helping providers offer more efficient, personalized care and enabling faster, data-driven

article thumbnail

New tentative approval for Alembic drug dabigatran etexilate mesylate

Drug Patent Watch

Dabigatran etexilate mesylate is the generic ingredient in two branded drugs marketed by Alkem Labs Ltd, Apotex, Hetero Labs Ltd Iii, and Boehringer Ingelheim and, and is included in five NDAs.

Drugs 59
article thumbnail

DENODO: Data virtualization tool

Perficient: Drug Development

WHAT IS DENODO: The Denodo Platform is a data virtualization framework in the market that uses logical approach to enable self-service BI, data science, hybrid/multi-cloud data integration, and enterprise data services. Today, several large Fortune 1000 companies leverage Denodo to support their mission-critical data virtualization strategies. A single view of enriched and transformed data from multiple data stores.

article thumbnail

Why Universal Design in Health Systems Matters for Improved Patient Experience – 3

Perficient: Drug Development

Welcome to the third installment of our Universal Design and Health System blog series. In this edition, we explore why Universal Design is crucial for enhancing patient experience within healthcare environments. Universal Design principles aim to create spaces and services that are accessible, inclusive, and user-friendly for all individuals, regardless of their abilities or disabilities.